2021
DOI: 10.3389/fnbeh.2021.699592
|View full text |Cite
|
Sign up to set email alerts
|

Functional Contribution of the Medial Prefrontal Circuitry in Major Depressive Disorder and Stress-Induced Depressive-Like Behaviors

Abstract: Despite decades of research on the neurobiology of major depressive disorder (MDD), the mechanisms underlying its expression remain unknown. The medial prefrontal cortex (mPFC), a hub region involved in emotional processing and stress response elaboration, is highly impacted in MDD patients and animal models of chronic stress. Recent advances showed alterations in the morphology and activity of mPFC neurons along with profound changes in their transcriptional programs. Studies at the circuitry level highlighte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(30 citation statements)
references
References 174 publications
(292 reference statements)
0
28
0
2
Order By: Relevance
“…In imaging studies of individuals with schizophrenia, the parietal cortex exhibited reduced gray matter [ 246 , 247 ]. Similarly, a reduction in gray matter and dendritic spine number was reported in the mPFC of patients with MDD [ 248 , 249 , 250 ]. Due to the current evidence demonstrating high levels of the pro-peptide in these brain regions, paired with its negative modulatory effect in various in vitro studies, it is reasonable to hypothesize that therapeutic regulation of BDNF pro-peptide expression would be beneficial, although this strategy would be complicated.…”
Section: The Bdnf Pro-peptide: a Functional “Third Ligand”mentioning
confidence: 67%
“…In imaging studies of individuals with schizophrenia, the parietal cortex exhibited reduced gray matter [ 246 , 247 ]. Similarly, a reduction in gray matter and dendritic spine number was reported in the mPFC of patients with MDD [ 248 , 249 , 250 ]. Due to the current evidence demonstrating high levels of the pro-peptide in these brain regions, paired with its negative modulatory effect in various in vitro studies, it is reasonable to hypothesize that therapeutic regulation of BDNF pro-peptide expression would be beneficial, although this strategy would be complicated.…”
Section: The Bdnf Pro-peptide: a Functional “Third Ligand”mentioning
confidence: 67%
“…mPFC, a hub region in the integration and consolidation of emotional responses to chronic stress, is highly impacted in depressive patients and animal models of chronic stress [ 4 , 56 ]. This complex process appears to involve a series of morphological and anatomical alterations combined with changes in the strength of mPFC inputs from several brain structures [ 57 ].…”
Section: Discussionmentioning
confidence: 99%
“…It is particularly true considering the low treatment efficacy despite various types of targeted antidepressant drugs. This persistent incapacity for treating depression efficiently results in part from the heterogeneity of the disorder and the insufficient understanding of the functional and molecular mechanisms underlying its onset [ 4 ]. Hence, this is urgent need for immediate and effective treatments for depression with fewer adverse events, and complementary and alternative medicinal therapies, particularly traditional Chinese medicine (TCM), are widely tested for this purpose [ 5 , 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…As a central hub that receives input from cortical, thalamic, and limbic regions and sends outputs to structures that regulate emotion, fear, and stress responses, the PFC has been demonstrated to be highly involved with emotional and cognitive processing, and to play a critical role in mood disorders, such as anxiety, depression, and schizophrenia. Previous studies reveal that the PFC is necessary and sufficient for the actions of ketamine ( Lepack et al, 2014 ; Fuchikami et al, 2015 ; Bittar and Labonte, 2021 ). Inactivation of the medial FPC (mPFC), a subregion of PFC, completely blocked the antidepressant and anxiolytic effects of systemic ketamine in rodent models.…”
Section: Prefrontal Cortex As An Important Region Mediating the Antid...mentioning
confidence: 99%